nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—liver cancer	0.689	1	CbGaD
Cephalexin—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.00741	0.0318	CcSEcCtD
Cephalexin—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.00569	0.0244	CcSEcCtD
Cephalexin—Blood bilirubin increased—Sorafenib—liver cancer	0.00461	0.0197	CcSEcCtD
Cephalexin—Prothrombin level increased—Epirubicin—liver cancer	0.00393	0.0168	CcSEcCtD
Cephalexin—Prothrombin level increased—Doxorubicin—liver cancer	0.00363	0.0156	CcSEcCtD
Cephalexin—Hepatic function abnormal—Sorafenib—liver cancer	0.00362	0.0155	CcSEcCtD
Cephalexin—Lactic dehydrogenase activity increased—Epirubicin—liver cancer	0.00315	0.0135	CcSEcCtD
Cephalexin—Anorectal discomfort—Epirubicin—liver cancer	0.00295	0.0126	CcSEcCtD
Cephalexin—Lactic dehydrogenase activity increased—Doxorubicin—liver cancer	0.00291	0.0125	CcSEcCtD
Cephalexin—Breast disorder—Sorafenib—liver cancer	0.00286	0.0123	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00285	0.0122	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00285	0.0122	CcSEcCtD
Cephalexin—Gastritis—Sorafenib—liver cancer	0.0028	0.012	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00279	0.012	CcSEcCtD
Cephalexin—Blood lactate dehydrogenase increased—Epirubicin—liver cancer	0.00277	0.0119	CcSEcCtD
Cephalexin—Anorectal discomfort—Doxorubicin—liver cancer	0.00273	0.0117	CcSEcCtD
Cephalexin—Vaginal discharge—Epirubicin—liver cancer	0.00265	0.0113	CcSEcCtD
Cephalexin—Blood lactate dehydrogenase increased—Doxorubicin—liver cancer	0.00256	0.011	CcSEcCtD
Cephalexin—Neutropenia—Sorafenib—liver cancer	0.00256	0.011	CcSEcCtD
Cephalexin—Vaginal discharge—Doxorubicin—liver cancer	0.00245	0.0105	CcSEcCtD
Cephalexin—Infestation—Sorafenib—liver cancer	0.00244	0.0104	CcSEcCtD
Cephalexin—Infestation NOS—Sorafenib—liver cancer	0.00244	0.0104	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00242	0.0104	CcSEcCtD
Cephalexin—Hepatobiliary disease—Sorafenib—liver cancer	0.00231	0.00988	CcSEcCtD
Cephalexin—Haemoglobin—Sorafenib—liver cancer	0.0022	0.00943	CcSEcCtD
Cephalexin—Haemorrhage—Sorafenib—liver cancer	0.00219	0.00938	CcSEcCtD
Cephalexin—Urinary tract disorder—Sorafenib—liver cancer	0.00216	0.00926	CcSEcCtD
Cephalexin—Connective tissue disorder—Sorafenib—liver cancer	0.00215	0.00922	CcSEcCtD
Cephalexin—Urethral disorder—Sorafenib—liver cancer	0.00214	0.0092	CcSEcCtD
Cephalexin—Erythema multiforme—Sorafenib—liver cancer	0.00207	0.00887	CcSEcCtD
Cephalexin—Immune system disorder—Sorafenib—liver cancer	0.00198	0.00847	CcSEcCtD
Cephalexin—Mental disorder—Sorafenib—liver cancer	0.00192	0.00822	CcSEcCtD
Cephalexin—Jaundice cholestatic—Epirubicin—liver cancer	0.00183	0.00786	CcSEcCtD
Cephalexin—Arthropathy—Epirubicin—liver cancer	0.00177	0.00759	CcSEcCtD
Cephalexin—Angioedema—Sorafenib—liver cancer	0.00174	0.00746	CcSEcCtD
Cephalexin—Leukopenia—Sorafenib—liver cancer	0.00171	0.00731	CcSEcCtD
Cephalexin—Blood bilirubin increased—Epirubicin—liver cancer	0.0017	0.0073	CcSEcCtD
Cephalexin—Jaundice cholestatic—Doxorubicin—liver cancer	0.0017	0.00727	CcSEcCtD
Cephalexin—Creatinine increased—Epirubicin—liver cancer	0.00169	0.00725	CcSEcCtD
Cephalexin—Arthropathy—Doxorubicin—liver cancer	0.00164	0.00702	CcSEcCtD
Cephalexin—Arthralgia—Sorafenib—liver cancer	0.00162	0.00695	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00161	0.0069	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Epirubicin—liver cancer	0.00161	0.0069	CcSEcCtD
Cephalexin—Vaginal inflammation—Epirubicin—liver cancer	0.00161	0.0069	CcSEcCtD
Cephalexin—Blood bilirubin increased—Doxorubicin—liver cancer	0.00158	0.00675	CcSEcCtD
Cephalexin—Creatinine increased—Doxorubicin—liver cancer	0.00157	0.00671	CcSEcCtD
Cephalexin—Anaphylactic shock—Sorafenib—liver cancer	0.00155	0.00666	CcSEcCtD
Cephalexin—Colitis—Epirubicin—liver cancer	0.00155	0.00663	CcSEcCtD
Cephalexin—Nervous system disorder—Sorafenib—liver cancer	0.00152	0.00654	CcSEcCtD
Cephalexin—Thrombocytopenia—Sorafenib—liver cancer	0.00152	0.00652	CcSEcCtD
Cephalexin—Blood urea increased—Epirubicin—liver cancer	0.00152	0.00652	CcSEcCtD
Cephalexin—Vaginal infection—Epirubicin—liver cancer	0.00152	0.00652	CcSEcCtD
Cephalexin—Aplastic anaemia—Epirubicin—liver cancer	0.00151	0.00648	CcSEcCtD
Cephalexin—Skin disorder—Sorafenib—liver cancer	0.00151	0.00647	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00149	0.00639	CcSEcCtD
Cephalexin—Vaginal inflammation—Doxorubicin—liver cancer	0.00149	0.00639	CcSEcCtD
Cephalexin—Colitis—Doxorubicin—liver cancer	0.00143	0.00613	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00142	0.00607	CcSEcCtD
Cephalexin—Blood urea increased—Doxorubicin—liver cancer	0.00141	0.00603	CcSEcCtD
Cephalexin—Vaginal infection—Doxorubicin—liver cancer	0.00141	0.00603	CcSEcCtD
Cephalexin—Aplastic anaemia—Doxorubicin—liver cancer	0.0014	0.006	CcSEcCtD
Cephalexin—Dyspepsia—Sorafenib—liver cancer	0.00137	0.00587	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00134	0.00576	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00134	0.00575	CcSEcCtD
Cephalexin—Fatigue—Sorafenib—liver cancer	0.00134	0.00575	CcSEcCtD
Cephalexin—Hepatic function abnormal—Epirubicin—liver cancer	0.00134	0.00573	CcSEcCtD
Cephalexin—Gastrointestinal pain—Sorafenib—liver cancer	0.00127	0.00545	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00124	0.00533	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—liver cancer	0.00124	0.00531	CcSEcCtD
Cephalexin—Urticaria—Sorafenib—liver cancer	0.00124	0.00529	CcSEcCtD
Cephalexin—Body temperature increased—Sorafenib—liver cancer	0.00123	0.00527	CcSEcCtD
Cephalexin—Abdominal pain—Sorafenib—liver cancer	0.00123	0.00527	CcSEcCtD
Cephalexin—Osteoarthritis—Epirubicin—liver cancer	0.00117	0.00501	CcSEcCtD
Cephalexin—Hypersensitivity—Sorafenib—liver cancer	0.00115	0.00491	CcSEcCtD
Cephalexin—Asthenia—Sorafenib—liver cancer	0.00112	0.00478	CcSEcCtD
Cephalexin—Pruritus—Sorafenib—liver cancer	0.0011	0.00471	CcSEcCtD
Cephalexin—Blood creatinine increased—Epirubicin—liver cancer	0.0011	0.00469	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—liver cancer	0.00108	0.00464	CcSEcCtD
Cephalexin—Diarrhoea—Sorafenib—liver cancer	0.00106	0.00456	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—liver cancer	0.00106	0.00453	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00105	0.00451	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00105	0.00451	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—liver cancer	0.00103	0.00443	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00103	0.00442	CcSEcCtD
Cephalexin—Dizziness—Sorafenib—liver cancer	0.00103	0.00441	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—liver cancer	0.00101	0.00434	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—liver cancer	0.001	0.00429	CcSEcCtD
Cephalexin—Vomiting—Sorafenib—liver cancer	0.000988	0.00424	CcSEcCtD
Cephalexin—Rash—Sorafenib—liver cancer	0.00098	0.0042	CcSEcCtD
Cephalexin—Dermatitis—Sorafenib—liver cancer	0.000979	0.0042	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—liver cancer	0.000977	0.00419	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000974	0.00418	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000974	0.00418	CcSEcCtD
Cephalexin—Headache—Sorafenib—liver cancer	0.000974	0.00417	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—liver cancer	0.000959	0.00411	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—liver cancer	0.000957	0.0041	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000954	0.00409	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—liver cancer	0.000945	0.00405	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—liver cancer	0.000926	0.00397	CcSEcCtD
Cephalexin—Nausea—Sorafenib—liver cancer	0.000923	0.00396	CcSEcCtD
Cephalexin—Infestation—Epirubicin—liver cancer	0.000901	0.00386	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—liver cancer	0.000901	0.00386	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000893	0.00383	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—liver cancer	0.000888	0.00381	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—liver cancer	0.000874	0.00375	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—liver cancer	0.000852	0.00365	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—liver cancer	0.000841	0.0036	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—liver cancer	0.000834	0.00357	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—liver cancer	0.000834	0.00357	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000826	0.00354	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—liver cancer	0.000813	0.00348	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—liver cancer	0.000809	0.00347	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—liver cancer	0.000809	0.00347	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—liver cancer	0.000799	0.00342	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—liver cancer	0.000795	0.00341	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—liver cancer	0.000793	0.0034	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—liver cancer	0.000788	0.00338	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—liver cancer	0.000778	0.00333	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—liver cancer	0.000765	0.00328	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—liver cancer	0.000752	0.00322	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—liver cancer	0.000748	0.00321	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—liver cancer	0.000748	0.00321	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—liver cancer	0.000739	0.00317	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—liver cancer	0.000735	0.00315	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—liver cancer	0.000733	0.00314	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—liver cancer	0.00073	0.00313	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—liver cancer	0.000708	0.00304	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—liver cancer	0.000707	0.00303	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—liver cancer	0.000676	0.0029	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—liver cancer	0.000656	0.00281	CcSEcCtD
Cephalexin—Agitation—Epirubicin—liver cancer	0.000647	0.00277	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—liver cancer	0.00063	0.0027	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—liver cancer	0.00061	0.00261	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—liver cancer	0.000599	0.00257	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—liver cancer	0.000599	0.00257	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000595	0.00255	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—liver cancer	0.000583	0.0025	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—liver cancer	0.000579	0.00248	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—liver cancer	0.000575	0.00246	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—liver cancer	0.000564	0.00242	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—liver cancer	0.000563	0.00242	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—liver cancer	0.000563	0.00241	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—liver cancer	0.000558	0.00239	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—liver cancer	0.000555	0.00238	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000551	0.00236	CcSEcCtD
Cephalexin—Cefpiramide—ALB—liver cancer	0.000545	0.325	CrCbGaD
Cephalexin—Confusional state—Doxorubicin—liver cancer	0.000536	0.0023	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—liver cancer	0.000532	0.00228	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000523	0.00224	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—liver cancer	0.000521	0.00223	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—liver cancer	0.00052	0.00223	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—liver cancer	0.000516	0.00221	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—liver cancer	0.000506	0.00217	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—liver cancer	0.000496	0.00213	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—liver cancer	0.000495	0.00212	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000484	0.00208	CcSEcCtD
Cephalexin—Cefonicid—ALB—liver cancer	0.000475	0.283	CrCbGaD
Cephalexin—Feeling abnormal—Epirubicin—liver cancer	0.000473	0.00203	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—liver cancer	0.00047	0.00201	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—liver cancer	0.000468	0.00201	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000459	0.00197	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—liver cancer	0.000458	0.00196	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—liver cancer	0.000456	0.00196	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—liver cancer	0.000454	0.00195	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—liver cancer	0.000454	0.00195	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—liver cancer	0.000438	0.00188	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000435	0.00186	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—liver cancer	0.000423	0.00181	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—liver cancer	0.000422	0.00181	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—liver cancer	0.00042	0.0018	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—liver cancer	0.00042	0.0018	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—liver cancer	0.000412	0.00177	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—liver cancer	0.000406	0.00174	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—liver cancer	0.000393	0.00169	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—liver cancer	0.000392	0.00168	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—liver cancer	0.000381	0.00164	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—liver cancer	0.00038	0.00163	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—liver cancer	0.000376	0.00161	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—liver cancer	0.000365	0.00157	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—liver cancer	0.000364	0.00156	CcSEcCtD
Cephalexin—Rash—Epirubicin—liver cancer	0.000362	0.00155	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—liver cancer	0.000362	0.00155	CcSEcCtD
Cephalexin—Headache—Epirubicin—liver cancer	0.00036	0.00154	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—liver cancer	0.000352	0.00151	CcSEcCtD
Cephalexin—Nausea—Epirubicin—liver cancer	0.000341	0.00146	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—liver cancer	0.000338	0.00145	CcSEcCtD
Cephalexin—Rash—Doxorubicin—liver cancer	0.000335	0.00144	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—liver cancer	0.000335	0.00144	CcSEcCtD
Cephalexin—Headache—Doxorubicin—liver cancer	0.000333	0.00143	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—liver cancer	0.000316	0.00135	CcSEcCtD
Cephalexin—Ampicillin—ALB—liver cancer	0.000238	0.142	CrCbGaD
Cephalexin—Cefazolin—ALB—liver cancer	0.00023	0.137	CrCbGaD
Cephalexin—Cefalotin—ALB—liver cancer	0.000191	0.114	CrCbGaD
Cephalexin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000138	0.00182	CbGpPWpGaD
Cephalexin—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000137	0.00182	CbGpPWpGaD
Cephalexin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000132	0.00175	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000131	0.00173	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—SERPINE1—liver cancer	0.00013	0.00172	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—SERPINA1—liver cancer	0.00013	0.00171	CbGpPWpGaD
Cephalexin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000125	0.00166	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000125	0.00165	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—F2—liver cancer	0.000124	0.00164	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000122	0.00161	CbGpPWpGaD
Cephalexin—SLC15A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000121	0.0016	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.00012	0.00159	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000119	0.00157	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000118	0.00155	CbGpPWpGaD
Cephalexin—SLC15A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000112	0.00148	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—SERPINE1—liver cancer	0.000111	0.00147	CbGpPWpGaD
Cephalexin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000111	0.00147	CbGpPWpGaD
Cephalexin—SLC22A5—SLC-mediated transmembrane transport—ALB—liver cancer	0.00011	0.00146	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.00011	0.00145	CbGpPWpGaD
Cephalexin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00011	0.00145	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000109	0.00144	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000108	0.00143	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000108	0.00142	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—CYCS—liver cancer	0.000107	0.00142	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000107	0.00141	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—liver cancer	0.000106	0.0014	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL2—liver cancer	0.000105	0.00139	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000103	0.00137	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000103	0.00136	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000102	0.00135	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000102	0.00135	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000102	0.00135	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—ANXA2—liver cancer	0.000101	0.00133	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000101	0.00133	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.0001	0.00133	CbGpPWpGaD
Cephalexin—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	9.98e-05	0.00132	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—RAF1—liver cancer	9.73e-05	0.00129	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	9.71e-05	0.00128	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—SLC11A2—liver cancer	9.56e-05	0.00126	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—HMOX1—liver cancer	9.49e-05	0.00125	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—TNF—liver cancer	9.41e-05	0.00124	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GGT1—liver cancer	9.35e-05	0.00124	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—HMOX1—liver cancer	9.34e-05	0.00123	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—SLC40A1—liver cancer	9.12e-05	0.0012	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	9.02e-05	0.00119	CbGpPWpGaD
Cephalexin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	9e-05	0.00119	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—ANXA2—liver cancer	8.74e-05	0.00116	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—ATP7B—liver cancer	8.74e-05	0.00116	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	8.69e-05	0.00115	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	8.57e-05	0.00113	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PRKCE—liver cancer	8.55e-05	0.00113	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	8.44e-05	0.00112	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTP1—liver cancer	8.4e-05	0.00111	CbGpPWpGaD
Cephalexin—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	8.33e-05	0.0011	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	8.28e-05	0.00109	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—NR1H4—liver cancer	8.27e-05	0.00109	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—PPARA—liver cancer	8.26e-05	0.00109	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—HPGDS—liver cancer	8.17e-05	0.00108	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	8.11e-05	0.00107	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—IGF2—liver cancer	8.1e-05	0.00107	CbGpPWpGaD
Cephalexin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	7.88e-05	0.00104	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTM1—liver cancer	7.72e-05	0.00102	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—PPARA—liver cancer	7.67e-05	0.00101	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—VEGFA—liver cancer	7.66e-05	0.00101	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—TNF—liver cancer	7.65e-05	0.00101	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—HGF—liver cancer	7.65e-05	0.00101	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	7.61e-05	0.00101	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—IL6—liver cancer	7.59e-05	0.001	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—CSF2—liver cancer	7.56e-05	0.000999	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—PPARA—liver cancer	7.54e-05	0.000997	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—CYP1A1—liver cancer	7.32e-05	0.000967	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	7.29e-05	0.000964	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	7.22e-05	0.000953	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	7.05e-05	0.000931	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—TGFB1—liver cancer	7.03e-05	0.000929	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	6.82e-05	0.000901	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—TP53—liver cancer	6.75e-05	0.000892	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	6.7e-05	0.000885	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINA1—liver cancer	6.69e-05	0.000884	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—CYP2E1—liver cancer	6.66e-05	0.00088	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.65e-05	0.000878	CbGpPWpGaD
Cephalexin—ALB—Metabolism—UGDH—liver cancer	6.63e-05	0.000876	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	6.57e-05	0.000868	CbGpPWpGaD
Cephalexin—ALB—Metabolism—EPT1—liver cancer	6.23e-05	0.000823	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL6—liver cancer	6.18e-05	0.000816	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—ALB—liver cancer	6.14e-05	0.000811	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—MAPK14—liver cancer	6.12e-05	0.000809	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GGT1—liver cancer	6.11e-05	0.000808	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—TNF—liver cancer	6.08e-05	0.000803	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—F2—liver cancer	5.93e-05	0.000784	CbGpPWpGaD
Cephalexin—ALB—Metabolism—TAT—liver cancer	5.91e-05	0.00078	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.81e-05	0.000768	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—ALB—liver cancer	5.7e-05	0.000753	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	5.69e-05	0.000752	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	5.68e-05	0.00075	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—ALB—liver cancer	5.61e-05	0.000741	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—RAF1—liver cancer	5.55e-05	0.000734	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.49e-05	0.000725	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—UGDH—liver cancer	5.47e-05	0.000723	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.42e-05	0.000716	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—RAF1—liver cancer	5.15e-05	0.000681	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—EPT1—liver cancer	5.14e-05	0.00068	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—RAF1—liver cancer	5.07e-05	0.00067	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	5.07e-05	0.00067	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.05e-05	0.000667	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	4.99e-05	0.00066	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IFNA1—liver cancer	4.98e-05	0.000658	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.98e-05	0.000658	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	4.94e-05	0.000652	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—IL6—liver cancer	4.91e-05	0.000648	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TAT—liver cancer	4.88e-05	0.000644	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.78e-05	0.000632	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.72e-05	0.000623	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	4.58e-05	0.000606	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	4.46e-05	0.000589	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PRKCE—liver cancer	4.41e-05	0.000582	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	4.35e-05	0.000575	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.35e-05	0.000575	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	4.23e-05	0.000559	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	4.21e-05	0.000557	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—ABL1—liver cancer	4.19e-05	0.000554	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IGF2—liver cancer	4.17e-05	0.000552	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GLUL—liver cancer	4.02e-05	0.000531	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CPT1B—liver cancer	4.02e-05	0.000531	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	4e-05	0.000528	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HGF—liver cancer	3.94e-05	0.000521	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CSF2—liver cancer	3.9e-05	0.000515	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NR1H4—liver cancer	3.87e-05	0.000512	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	3.83e-05	0.000506	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTA3—liver cancer	3.81e-05	0.000503	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	3.66e-05	0.000484	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—UGDH—liver cancer	3.58e-05	0.000473	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTA4—liver cancer	3.48e-05	0.00046	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.4e-05	0.00045	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	3.4e-05	0.000449	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTA2—liver cancer	3.39e-05	0.000448	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—EPT1—liver cancer	3.36e-05	0.000444	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CPT1B—liver cancer	3.32e-05	0.000438	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GLUL—liver cancer	3.32e-05	0.000438	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTA1—liver cancer	3.27e-05	0.000432	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NAT2—liver cancer	3.24e-05	0.000428	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NR1H4—liver cancer	3.2e-05	0.000422	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TAT—liver cancer	3.19e-05	0.000421	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MAPK14—liver cancer	3.16e-05	0.000417	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA3—liver cancer	3.14e-05	0.000415	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	3.12e-05	0.000412	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.11e-05	0.000411	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ALDOB—liver cancer	3.1e-05	0.00041	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—F2—liver cancer	3.06e-05	0.000404	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CRABP1—liver cancer	2.96e-05	0.000391	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.96e-05	0.000391	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CG—liver cancer	2.93e-05	0.000387	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA4—liver cancer	2.87e-05	0.00038	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA2—liver cancer	2.8e-05	0.00037	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA1—liver cancer	2.7e-05	0.000357	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NAT2—liver cancer	2.67e-05	0.000353	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.67e-05	0.000352	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.65e-05	0.000351	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HPGDS—liver cancer	2.59e-05	0.000342	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CD—liver cancer	2.57e-05	0.00034	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.57e-05	0.00034	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALDOB—liver cancer	2.56e-05	0.000339	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINE1—liver cancer	2.55e-05	0.000336	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CRABP1—liver cancer	2.44e-05	0.000323	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.34e-05	0.00031	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PSMD10—liver cancer	2.31e-05	0.000305	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PSMA4—liver cancer	2.31e-05	0.000305	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—RAF1—liver cancer	2.3e-05	0.000304	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GOT2—liver cancer	2.24e-05	0.000296	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CB—liver cancer	2.24e-05	0.000296	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CPT1B—liver cancer	2.17e-05	0.000286	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GLUL—liver cancer	2.17e-05	0.000286	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	2.17e-05	0.000286	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HPGDS—liver cancer	2.14e-05	0.000282	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP2E1—liver cancer	2.11e-05	0.000279	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NR1H4—liver cancer	2.09e-05	0.000276	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL2—liver cancer	2.06e-05	0.000272	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA3—liver cancer	2.05e-05	0.000271	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.04e-05	0.00027	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.99e-05	0.000263	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYCS—liver cancer	1.97e-05	0.000261	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GGT1—liver cancer	1.94e-05	0.000256	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GOT1—liver cancer	1.94e-05	0.000256	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PSMD10—liver cancer	1.9e-05	0.000252	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PSMA4—liver cancer	1.9e-05	0.000252	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA4—liver cancer	1.88e-05	0.000248	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GOT2—liver cancer	1.85e-05	0.000245	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA2—liver cancer	1.83e-05	0.000242	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA1—liver cancer	1.77e-05	0.000233	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—VEGFA—liver cancer	1.75e-05	0.000231	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAT2—liver cancer	1.75e-05	0.000231	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP2E1—liver cancer	1.74e-05	0.00023	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTP1—liver cancer	1.74e-05	0.00023	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HMOX1—liver cancer	1.72e-05	0.000227	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALDOB—liver cancer	1.68e-05	0.000221	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYCS—liver cancer	1.63e-05	0.000215	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB1—liver cancer	1.61e-05	0.000212	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GGT1—liver cancer	1.6e-05	0.000211	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GOT1—liver cancer	1.6e-05	0.000211	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTM1—liver cancer	1.6e-05	0.000211	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CRABP1—liver cancer	1.6e-05	0.000211	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP1A1—liver cancer	1.52e-05	0.0002	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—KRAS—liver cancer	1.49e-05	0.000197	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTP1—liver cancer	1.44e-05	0.00019	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMOX1—liver cancer	1.42e-05	0.000187	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTHFR—liver cancer	1.41e-05	0.000187	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HPGDS—liver cancer	1.4e-05	0.000185	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARA—liver cancer	1.39e-05	0.000183	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CA—liver cancer	1.37e-05	0.000181	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TP53—liver cancer	1.32e-05	0.000175	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTM1—liver cancer	1.32e-05	0.000174	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HRAS—liver cancer	1.27e-05	0.000167	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP1A1—liver cancer	1.25e-05	0.000165	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.24e-05	0.000164	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PSMD10—liver cancer	1.24e-05	0.000164	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PSMA4—liver cancer	1.24e-05	0.000164	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GOT2—liver cancer	1.21e-05	0.00016	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CG—liver cancer	1.19e-05	0.000157	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTHFR—liver cancer	1.17e-05	0.000154	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARG—liver cancer	1.15e-05	0.000151	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARA—liver cancer	1.14e-05	0.000151	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP2E1—liver cancer	1.14e-05	0.00015	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—AKT1—liver cancer	1.12e-05	0.000148	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYCS—liver cancer	1.07e-05	0.000141	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GGT1—liver cancer	1.05e-05	0.000138	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GOT1—liver cancer	1.05e-05	0.000138	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CD—liver cancer	1.04e-05	0.000138	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CG—liver cancer	9.8e-06	0.000129	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARG—liver cancer	9.46e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTP1—liver cancer	9.39e-06	0.000124	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMOX1—liver cancer	9.26e-06	0.000122	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CB—liver cancer	9.09e-06	0.00012	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM1—liver cancer	8.63e-06	0.000114	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CD—liver cancer	8.62e-06	0.000114	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALB—liver cancer	8.5e-06	0.000112	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP1A1—liver cancer	8.18e-06	0.000108	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTHFR—liver cancer	7.63e-06	0.000101	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CB—liver cancer	7.51e-06	9.92e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARA—liver cancer	7.48e-06	9.89e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CG—liver cancer	6.41e-06	8.47e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARG—liver cancer	6.18e-06	8.17e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CD—liver cancer	5.63e-06	7.44e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALB—liver cancer	5.56e-06	7.35e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CA—liver cancer	5.54e-06	7.33e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CB—liver cancer	4.91e-06	6.49e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CA—liver cancer	4.58e-06	6.05e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AKT1—liver cancer	4.53e-06	5.98e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AKT1—liver cancer	3.74e-06	4.94e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CA—liver cancer	2.99e-06	3.95e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AKT1—liver cancer	2.44e-06	3.23e-05	CbGpPWpGaD
